8-KThe WireStrategic
Exit / Disposal Costs
Filed Jan 4, 2024 · 2y ago · Accession 0001193125-24-002563
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Jan 4, 2024
- Report date
- Jan 1, 2024
- Document
- d35101d8k.htm
- Size
- 141 KB